Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Packaging of MDIs

Posted on By

SOP for Packaging of MDIs

MDI Packaging Procedures

1) Purpose

The purpose of this SOP is to define the packaging procedures for metered-dose inhalers (MDIs) to ensure product integrity, safety, and compliance with regulatory requirements.

2) Scope

This SOP applies to all personnel involved in the packaging of MDIs at the manufacturing facility, including packaging operators, supervisors, and quality assurance staff.

3) Responsibilities

The responsibilities for this SOP include ensuring proper packaging of MDIs, maintaining packaging equipment, and documenting the packaging process. Specific roles include:
Packaging Operators: Execute the packaging steps as outlined.
Supervisors: Oversee the packaging process and ensure compliance.
Quality Assurance: Inspect and document the packaging process.

See also  SOP for Stability Testing of MDIs

4) Procedure

4.1 Preparation
4.1.1 Verify the packaging materials against the bill of materials.
4.1.2 Clean and set up the packaging equipment as per the standard operating procedure.
4.2 Packaging Process
4.2.1 Load the MDIs onto the packaging line.
4.2.2 Ensure the correct labeling of each MDI unit.
4.2.3 Pack the labeled MDIs into the primary packaging (e.g., boxes).
4.2.4 Conduct in-process checks to ensure packaging accuracy.
4.3 Secondary Packaging
4.3.1 Transfer the primary packages to the secondary packaging area.
4.3.2 Pack the primary packages into shipping boxes or cartons.
4.3.3 Label the secondary packages with batch information and handling instructions.
4.4 Final Inspection
4.4.1 Inspect the packaged MDIs for any defects or inconsistencies.
4.4.2 Record the inspection results in the packaging log.
4.5 Storage and Handling
4.5.1 Store the packaged MDIs in designated storage areas.
4.5.2 Ensure proper handling and transportation conditions to maintain product integrity.

See also  SOP for Annual Product Review in MDI Production

5) Abbreviations, if any

MDI: Metered-Dose Inhaler

6) Documents, if any

Packaging records, equipment maintenance logs, and inspection reports should be maintained.

7) Reference, if any

Refer to regulatory guidelines from agencies such as the FDA, EMA, and ICH for packaging standards.

8) SOP Version

Version 1.0

Metered-Dose Inhaler Tags:Analytical Method Development MDIs, Batch Manufacturing Record MDI, Calibration MDI Equipment, Cleaning Equipment MDIs, Color Consistency Testing MDI, Contamination Prevention MDI, Documentation MDI Manufacturing, Final Product Inspection MDI, Formulation Development MDI, In-process Testing Inhalers, Inhaler Manufacturing Procedures, Inhaler Quality Control SOP, Labeling MDI SOP, MDI Production SOPs, MDI Storage Conditions, Metered-Dose Inhaler SOP, Microbial Testing Inhalers, Packaging of MDIs Procedure, Particle Size Analysis MDIs, Preservative Efficacy MDIs, Process Optimization MDIs, Process Validation MDIs, Propellant Testing MDIs, Quality Testing MDIs, Raw Material Inspection MDIs, Solvents Use in MDI Production, Stability Testing MDIs, Sterility Maintenance MDI, Training Personnel MDI Production, Waste Disposal MDI Production

Post navigation

Previous Post: SOP for Distribution and Transport Conditions for Transdermal Patches
Next Post: SOP for Visual Inspection of Transdermal Patches

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version